Y. Hirota et al., P53 ANTISENSE OLIGONUCLEOTIDE INHIBITS GROWTH OF HUMAN COLON-TUMOR AND NORMAL-CELL LINES, Japanese journal of cancer research, 87(7), 1996, pp. 735-742
We examined the relationship between the expression of mutant p53 prot
eins and tumor cell growth using a p53 antisense oligonucleotide (5'-C
CCTGCTCCCCCCTGGCTCC-3'). The oligonucleotide inhibited the growth of t
hree human colon tumor cell lines (DLD-1, SW620 and WiDr), which produ
ce only mutant p53 proteins with different mutation sites. Treatment o
f DLD-1 cells with the p53 antisense oligonucleotide caused a decrease
in the level of p53 mutant protein. Synthesis of DNA in DLD-1 and SW6
20 cells was inhibited more potently than that of RNA or protein after
antisense treatment. Furthermore, these cells were accumulated in the
S phase when DNA synthesis was inhibited. Meanwhile, the antisense ol
igonucleotide also inhibited the growth of three human normal cell lin
es (WI-38, TIG-1 and Intestine 407). While treatment of WI-38 and TIG-
1 cells with the antisense oligonucleotide inhibited synthesis of DNA
more potently than that of RNA or protein, these normal cells were acc
umulated in the G0/G1 phase. These results suggest that p53 proteins,
either with or without mutation, play a pivotal role in the growth of
tumor and normal cells, but that mutant and wild-type p53 proteins may
function differently in cell growth.